The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial

OBJECTIVE: To compare the efficacy and safety of mirabegron 50 mg and solifenacin 5 mg in overactive bladder (OAB) patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy. PATIENTS AND METHODS: This randomized, double-blind, phase IIIb, noninferiority study, enrolled mal...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Ther Adv Urol
Huvudupphovsmän: Batista, Jose E., Kölbl, Heinz, Herschorn, Sender, Rechberger, Tomasz, Cambronero, Javier, Halaska, Michael, Coppell, Alex, Kaper, Mathilde, Huang, Moses, Siddiqui, Emad
Materialtyp: Artigo
Språk:Inglês
Publicerad: SAGE Publications 2015
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4580095/
https://ncbi.nlm.nih.gov/pubmed/26445596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287215589250
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk